1-8 of 8
A Neubauer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses

Jana von Jan, Sanna Timonen, Till Braun, Qu Jiang, Aleksandr Ianevski, Yayi Peng, Kathleen McConnell, Paola Sindaco, Tony Andreas Müller, Sabine Pützer, Hanna Klepzig, Dennis Jungherz, Annika Dechow, Linus Wahnschaffe, Anil K. Giri, Matti Kankainen, Heikki Kuusanmäki, Heidi A. Neubauer, Richard Moriggl, Paolo Mazzeo, Nicole Schmidt, Raphael Koch, Michael Hallek, Amel Chebel, David Armisen, Laurent Genestier, Emmanuel Bachy, Anjali Mishra, Alexandra Schrader, Tero Aittokallio, Satu Mustjoki, Marco Herling
Journal: Blood
Blood (2024) 144 (15): 1595–1610.
https://doi.org/10.1182/blood.2023022884
Published: 2024
Includes: Supplemental data
Journal Articles

Safety and Efficacy of a Combination of Imatinib and Pegylated Interferon α2a (Pegasys®) in Newly Diagnosed Patients with Chronic Myelogenous Leukemia - A Phase II Cohort Study.

Andreas Hochhaus, MD, A. Neubauer, MD, M.C. Mueller, MD, T. Fischer, MD, C. Waller, MD, T.H. Bruemmendorf, MD, T. Bostel, C. Lengerke, MD, R. Hehlmann, MD, A. Burchert, MD
Journal: Blood
Blood (2007) 110 (11): 1027.
https://doi.org/10.1182/blood.V110.11.1027.1027
Published: 2007
Journal Articles

Molecular Long-Term Surveillance of CML Patients on Imatinib Therapy. Follow-Up of German Patients Treated within the IRIS Trial.

Martin C. Mueller, MD, P. Paschka, MD, T. Lahaye, MD, Ch. Lorentz, MD, N. Gattermann, MD, D. Niederwieser, MD, G. Ehninger, MD, St Fruehauf, MD, A. Neubauer, MD, Th. Fischer, MD, B. Schultheis, MD, S. Kreil, MD, U. Haus, PhD, R. Hehlmann, MD, A. Hochhaus, MD, the German CML Study Group
Journal: Blood
Blood (2004) 104 (11): 1003.
https://doi.org/10.1182/blood.V104.11.1003.1003
Published: 2004
Journal Articles

High sensitivity and specificity of a coagulation assay for the detection of heterozygous and homozygous factor V Leiden--based resistance to activated protein C [letter; comment]

M Riewald, G Hintz, M Ritter, M Schmidt, A Neubauer, H Riess
Journal: Blood
Blood (1996) 88 (11): 4398–4399.
https://doi.org/10.1182/blood.V88.11.4398.4398
Published: 1996
Journal Articles

Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis

A Neubauer, A Fiebeler, DK Graham, JP O'Bryan, CA Schmidt, P Barckow, S Serke, W Siegert, HR Snodgrass, D Huhn
Journal: Blood
Blood (1994) 84 (6): 1931–1941.
https://doi.org/10.1182/blood.V84.6.1931.1931
Published: 1994
Journal Articles

Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia

A Neubauer, RK Dodge, SL George, FR Davey, RT Silver, CA Schiffer, RJ Mayer, ED Ball, D Wurster-Hill, CD Bloomfield
Journal: Blood
Blood (1994) 83 (6): 1603–1611.
https://doi.org/10.1182/blood.V83.6.1603.1603
Published: 1994
Journal Articles

Mutations of the ras proto-oncogenes in childhood monosomy 7

A Neubauer, K Shannon, E Liu
Journal: Blood
Blood (1991) 77 (3): 594–598.
https://doi.org/10.1182/blood.V77.3.594.594
Published: 1991
Journal Articles

Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia

PC Cogswell, R Morgan, M Dunn, A Neubauer, P Nelson, NK Poland-Johnston, AA Sandberg, E Liu
Journal: Blood
Blood (1989) 74 (8): 2629–2633.
https://doi.org/10.1182/blood.V74.8.2629.2629
Published: 1989